Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2018 Feb 1.

Published in final edited form as: J Neurooncol. 2016 Nov 17;131(3):449–458. doi: 10.1007/s11060-016-2319-2

Table 1.

Characteristics of the Study Population

	N	Age^* (years)		Gender
	N	Median	Range	Male	Female	Unidentified
All GBM patients	112	54	24–80	72 (64%)	40 (36%)
All controls	58	49	24–79	30 (53%)	27 (47%)	1
Newly-diagnosed	66	55	27–80	41(62%)	25 (38%)
Recurrent	46	53	24–80	31 (67%)	15 (33%)
CCF cohort 1	45	54	24–80	27 (60%)	18 (40%)
CCF cohort 1 controls	14	39.5	26–63	9 (64%)	4 (29%)	1
CCF cohort 2	47	52	27–80	35 (74%)	12 (26%)
CCF cohort 2 controls	20	57	24–79	10 (50%)	10 (50%)
UAB cohort	20	56.5	44–64	10 (50%)	10 (50%)
UAB cohort controls	24	48.5	40–69	11(46%)	13 (54%)

^*

Age at sample collection